209 related articles for article (PubMed ID: 26777041)
1. The Effect of Recombinant Growth Hormone Treatment in Children with Idiopathic Short Stature and Low Insulin-Like Growth Factor-1 Levels.
Şıklar Z; Kocaay P; Çamtosun E; İsakoca M; Hacıhamdioğlu B; Savaş Erdeve Ş; Berberoğlu M
J Clin Res Pediatr Endocrinol; 2015 Dec; 7(4):301-6. PubMed ID: 26777041
[TBL] [Abstract][Full Text] [Related]
2. IGF-1 and growth response to adult height in a randomized GH treatment trial in short non-GH-deficient children.
Kriström B; Lundberg E; Jonsson B; Albertsson-Wikland K;
J Clin Endocrinol Metab; 2014 Aug; 99(8):2917-24. PubMed ID: 24823461
[TBL] [Abstract][Full Text] [Related]
3. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
[TBL] [Abstract][Full Text] [Related]
4. Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial.
Kim J; Suh BK; Ko CW; Lee KH; Shin CH; Hwang JS; Kim HS; Chung WY; Kim CJ; Han HS; Kwon NY; Cho SY; Yoo HW; Jin DK
J Endocrinol Invest; 2018 Apr; 41(4):475-483. PubMed ID: 29103133
[TBL] [Abstract][Full Text] [Related]
5. Recombinant growth hormone therapy in children with short stature in Kuwait: a cross-sectional study of use and treatment outcomes.
Al-Abdulrazzaq D; Al-Taiar A; Hassan K; Al-Basari I
BMC Endocr Disord; 2015 Dec; 15():76. PubMed ID: 26630987
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of discontinuous, insulin-like growth factor 1-dosing growth hormone treatment in young children with FGFR3 N540K-mutated hypochondroplasia.
Rothenbuhler A; Linglart A; Piquard C; Bougnères P
J Pediatr; 2012 May; 160(5):849-53. PubMed ID: 22137367
[TBL] [Abstract][Full Text] [Related]
7. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
Bouhours-Nouet N; Gatelais F; Boux de Casson F; Rouleau S; Coutant R
J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
[TBL] [Abstract][Full Text] [Related]
8. The effect of growth hormone treatment on height in children with idiopathic short stature.
Jeong HR; Shim YS; Lee HS; Hwang JS
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):629-33. PubMed ID: 24810558
[TBL] [Abstract][Full Text] [Related]
9. Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature.
Gascoin-Lachambre G; Trivin C; Brauner R; Souberbielle JC
Growth Horm IGF Res; 2007 Jun; 17(3):194-200. PubMed ID: 17321775
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K
J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting bone age maturation during 3 years of growth hormone treatment in patients with idiopathic growth hormone deficiency and idiopathic short stature: Analysis of data from the LG growth study.
Kang MJ; Kim EY; Shim YS; Jeong HR; Lee HJ; Yang S; Hwang IT
Medicine (Baltimore); 2019 Apr; 98(14):e14962. PubMed ID: 30946320
[TBL] [Abstract][Full Text] [Related]
12. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone treatment of idiopathic short stature: analysis of the database from KIGS, the Kabi Pharmacia International Growth Study.
Ranke MB; Lindberg A
Acta Paediatr Suppl; 1994 Dec; 406():18-23; discussion 24. PubMed ID: 7734807
[TBL] [Abstract][Full Text] [Related]
14. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
Ross JL; Lee PA; Gut R; Germak J
Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of IGF-based growth hormone (GH) dosing in nonGH-deficient (nonGHD) short stature children with low IGF-I is not related to basal IGF-I levels.
Cohen P; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG; Germak J;
Clin Endocrinol (Oxf); 2013 Mar; 78(3):405-14. PubMed ID: 22924571
[TBL] [Abstract][Full Text] [Related]
16. Baseline IGFBP - 3 as the Key Element to Predict Growth Response to Growth Hormone and IGF - 1 Therapy in Subjects with Non - GH Deficient Short Stature and IGF - 1 Deficiency.
Perez-Colon S; Lazareva O; Purushothaman R; Malik S; Ten S; Bhangoo A
Int J Endocrinol Metab; 2018 Jul; 16(3):e58928. PubMed ID: 30197657
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.
Albertsson-Wikland K; Aronson AS; Gustafsson J; Hagenäs L; Ivarsson SA; Jonsson B; Kriström B; Marcus C; Nilsson KO; Ritzén EM; Tuvemo T; Westphal O; Aman J
J Clin Endocrinol Metab; 2008 Nov; 93(11):4342-50. PubMed ID: 18728172
[TBL] [Abstract][Full Text] [Related]
18. Near normalization of adult height and body proportions by growth hormone in pycnodysostosis.
Rothenbühler A; Piquard C; Gueorguieva I; Lahlou N; Linglart A; Bougnères P
J Clin Endocrinol Metab; 2010 Jun; 95(6):2827-31. PubMed ID: 20357177
[TBL] [Abstract][Full Text] [Related]
19. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
[TBL] [Abstract][Full Text] [Related]
20. Relationship between vitamin D receptor (VDR) polymorphisms and the efficacy of recombinant human growth hormone (rhGH) treatment in children with idiopathic short stature.
Wang W; Luo XP; Cai LX; Cui ZR; Luo XY; Luo RK
Genet Mol Res; 2015 Sep; 14(3):10507-14. PubMed ID: 26400282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
